Journal Article DKFZ-2026-01984

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Cell Press Cambridge, Mass.

Cancer cell 44(9), 1779-1798.e14 () [10.1016/j.ccell.2026.07.011]
 GO

Abstract: T cell-mediated immune surveillance is critical for cancer control, yet its role in bone marrow malignancies remains poorly understood. Here, we integrate TCR profiling, HLA immunopeptidomics, and functional screening to characterize tumor-reactive T cells in the bone marrow of patients with multiple myeloma (MM) and acute myeloid leukemia (AML). These cells are transcriptionally defined by a conserved effector program distinct from the exhausted phenotype of tumor-reactive T cells in solid cancers. Immunopeptidomic profiling reveals a partially shared antigen landscape enriched for noncanonical peptides driving convergent TCR responses. We develop TFiT (tumor-reactive features in T cells), a transcriptional classifier that identifies these cells and stratifies immunotherapy, but not chemotherapy, response across independent MM and AML cohorts, supporting its specificity for T cell-mediated tumor control. These findings reveal a latent but activatable anti-tumor T cell compartment in bone marrow malignancies and provide a framework for engaging endogenous immunity in MM and AML.

Keyword(s): TCR repertoire ; TFiT ; acute myeloid leukemia ; bispecific antibodies ; bone marrow microenvironment ; immune biomarker ; immunopeptidomics ; multiple myeloma ; noncanonical antigens ; tumor-reactive T cells

Classification:

Note: #EA:A014#EA:B066#EA:D170#LA:A014# / #DKTKZFB26# / #NCTZFB26# / Volume 44, Issue 9, 14 September 2026, Pages 1779-1798.e14

Contributing Institute(s):
  1. NWG Hämatologie und Immune Engineering (A014)
  2. DKTK HD zentral (HD01)
  3. Chromatin-Netzwerke (B066)
  4. KKE Neuroimmunologie und Hirntumorimmunologie (D170)
  5. GMP-Einheit Zelluläre Therapie (D210)
  6. Stammzellen und Krebs (A010)
  7. Translationale Medizinische Onkologie (B340)
  8. Koordinierungsstelle NCT Heidelberg (HD02)
Research Program(s):
  1. 311 - Zellbiologie und Tumorbiologie (POF4-311) (POF4-311)

Appears in the scientific report 2026
Database coverage:
Medline ; OpenAccess ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 50 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > D170
Public records
Publications database
Open Access

 Record created 2026-08-11, last modified 2026-11-11


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)